BTG1 and Down syndrome: Nonetheless, two other studies ⎼ one carried out with 116 patients with Down syndrome and ALL, and the other including 533 B-ALL patients ⎼ demonstrated that isolated BTG1 deletion was not able to impact the prognosis of the patients.8